Hostname: page-component-848d4c4894-4hhp2 Total loading time: 0 Render date: 2024-06-02T03:09:38.892Z Has data issue: false hasContentIssue false
  • English
  • Français

The Hypocholesterolemic Effect of Nicotinic Acid and its Relationship to the Autonomic Nervous System

Published online by Cambridge University Press:  08 February 2018

A. Hoffer  and
M. J. Callbeck
Get access Rights & Permissions [Opens in a new window]

Extract

Nicotinic acid, well known physiologically and chemically as a vitamin if administered in small quantities, has many interesting additional properties when given in relatively large amounts. Altschul (2, 3) found that it markedly decreased the levels of cholesterol in rabbits made hypercholesterolemic by diet, and Altschul, Hoffer and Stephen (4) found that in divided dosages of three grams per day this vitamin produced appreciable decreases in the cholesterol levels of healthy young subjects and in patients from a general hospital. The decrease was related linearly to the initial cholesterol levels while the percentage decrease increased as the initial cholesterol levels were elevated. The incorporation of nicotinic acid into atherogenic diets inhibited the development of arteriosclerosis in rabbits (Altschul (2)). Of seventeen animals tested, two showed intense arteriosclerosis, six showed mild change, and nine showed no arteriosclerosis. Without nicotinic acid, at least thirteen of the rabbits would have had severe arteriosclerosis on the basis of many previous studies by Altschul (2) and by many other investigators.

Type
Original Articles
Information
Journal of Mental Science , Volume 103 , Issue 433 , October 1957 , pp. 810 - 820
Copyright
Copyright © Royal College of Psychiatrists, 1957 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1 Altschul, R., “Lowering of serum cholesterol by ultraviolet irradiation,” Geriatrics, 1955, 10, 208–213.Google Scholar
2 Idem , “Die Beeinflussung des Blutcholesterinspiegels und der experimentellen Atherosklerose durch Nikotinsäure,” Zeit, für Kreislaufforschung, 1956, 45, 573–576.Google Scholar
3 Idem , “Influence of nicotinic acid on cholesterol metabolism,” Meeting Amer. Soc. for Study of Arteriosclerosis, 1956. November 11-12.Google Scholar
4 Idem , Hoffer, A., and Stephen, J. D., “Influence of nicotinic acid on serum cholesterol in man,” Archives Biochem. and Biophysics, 1955, 54, 558–559.Google Scholar
5 Idem and Hoffer, A., Effect of nicotinic acid on cholesterol levels and B.M.R. of normal volunteers, 1957. (In press.) Google Scholar
6 Bleuler, E., Dementia Praecox or The Group of Schizophrenias, Transl. 1950. New York: International Universities Press Google Scholar
7 Dury, A., “Effects of epinephrine on lipid partition and metabolism in the rabbit,” Circ. Res., 1957, 5, 47–53.Google Scholar
8 Elles, S., “The metabolic effects of epinephrine and related amines,” Pharm. Reviews, 1956, 8, 485–562.Google Scholar
9 Funkenstein, D. H., Greenblatt, M., and Solomon, H. C., “A test which predicts the clinical effects of electro-shock treatment on schizophrenic patients,” Amer. J. Psychiatry, 1950, 106, 889–901.Google Scholar
10 Gellhorn, E., Physiological foundation of neurology and psychiatry, 1953. Minneapolis: The University of Minnesota Press Google Scholar
11 Hoffer, A., “Objective criteria for the diagnosis of schizophrenia,” Confinia Neurologica, 1954, 14, 385–390.Google Scholar
12 Idem , “Effect of atropine on blood pressure of patients with mental and emotional disease,” Arch. Neur. and Psychiat., 1954, 71, 80–86.Google Scholar
13 Idem , Osmond, H., Callbeck, M. J., and Kahan, I., “Treatment of schizophrenia with nicotinic acid and nicotinamide,” J. Clin. and Exper. Psychopathology, 1957. (In press.) Google Scholar
14 Lewis, N. D., and Piotrowski, Z., Depression, 1954. Edited by Hoch, P. H. and Zubin, J. New York: Grune and Stratton, Inc Google Scholar
15 O'Reilly, P. O., Demay, M., and Kotlowski, K., 1957. Private communication.Google Scholar
16 Parsons, W. B., Achor, R. W. P., Berge, K. G., McKenzie, B. F., and Barker, N. W., “The effect of large doses of nicotinic acid on the plasma and serum lipids of human beings with hypercholesterolemia,” Proc. Staff Meeting, Mayo Clinic, 1956, 31, 377–390.Google Scholar
17 Paolantonio, V., “Atti Dell Accademia Medico Chirurgica Di Perugia,” Nvova Sene, 1953-54, Vol. 5, Fasc. 5.Google Scholar
18 Raab, W., “Adrenergic cholinergic control of cardiac metabolism and function,” Advances in Cardiology, 1956. New York: S. Karger Google Scholar
19 Schmidtmann, M., and Huttich, M., “Die Bedeutung der Gefasswandreaktion fur die Arteriosklerose,” Virchow's Arch. path. Anat., 1928, 267, 601–624.Google Scholar
20 Weckowicz, T. E., “Reliability of mecholyl test,” Arch. Neur. and Psychiatry, 1956, 76, 109–111.Google Scholar
21 Westphal, K., and Hermann, F., “Pathogenese der essentiellen Hypertonie,” Ztschr. Klin. Med., 1925, 101, 566–583.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.